BetterLife Pharma (BETRF) Net Cash Flow (2010 - 2026)
BetterLife Pharma (BETRF) posted quarterly Net Cash Flow of $11545.2 for Q2 2026, up 52.76% year-over-year from $7557.8 in Q2 2025, and up 489.94% quarter-over-quarter from $1957.0 in Q3 2025.
BetterLife Pharma (BETRF) Net Cash Flow (2010 - 2026) Analysis & Trends
BetterLife Pharma's Net Cash Flow history runs 17 years deep, the most recent figure standing at $11545.2 for Q2 2026.
- In Q2 2026, Net Cash Flow rose 52.76% year-over-year to $11545.2; the TTM figure through Apr 2026 stood at $21060.0 (up 107.13% YoY), while the FY2026 annual figure was $2743.9, up 113.33% from the prior year.
- Net Cash Flow for Q2 2026 stood at $11545.2, up from $1957.0 in the prior quarter.
- The five-year high for Net Cash Flow was $284289.0 in Q2 2024, with the low at -$1.5 million in Q1 2022.
- The 5-year median for Net Cash Flow is -$4670.6 (2022), against an average of -$103005.2.
- Peak annual rise in Net Cash Flow reached 246.87% in 2023, while the deepest fall reached 7055.53% in 2023.
- BetterLife Pharma's Net Cash Flow stood at $18064.2 in 2022, then rose by 28.72% to $23251.7 in 2023, then slumped by 438.96% to -$78814.8 in 2024, then soared by 102.48% to $1957.0 in 2025, then surged by 489.94% to $11545.2 in 2026.
- Business Quant data shows BETRF's Net Cash Flow at $11545.2 in Q2 2026, $1957.0 in Q3 2025, and $7557.8 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - | 11,545.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 11,545.16 |
| Apr 30, 2026 | 11,545.16 |
| Jul 31, 2025 | 1,957.01 |
| Jul 31, 2025 | 1,957.01 |
| Apr 30, 2025 | 7,557.85 |
| Apr 30, 2025 | 7,557.85 |
| Jan 31, 2025 | -7,388.73 |
| Jan 31, 2025 | -7,388.73 |
| Oct 31, 2024 | -78,814.77 |
| Oct 31, 2024 | -78,814.77 |
| Jul 31, 2024 | -216,582.05 |
| Jul 31, 2024 | -216,582.05 |
| Apr 30, 2024 | 284,288.99 |
| Apr 30, 2024 | 284,288.99 |
| Jan 31, 2024 | -40,781.58 |
| Jan 31, 2024 | -40,781.58 |
| Oct 31, 2023 | 23,251.71 |
| Oct 31, 2023 | 23,251.71 |
| Jul 31, 2023 | -139,702.54 |
| Jul 31, 2023 | -139,702.54 |